Alzheimer’s Archives

Healthcare Industry News Weekly Wrap-Up: April 14, 2023

// Biotech and Pharma Therapeutics VBI Vaccines pares down pipeline and staff to focus on hepatitis B programs April 4, 2023 / VBI Vaccines / Layoffs / Hepatitis B / Covid-19 The company will zero in on approved hepatitis B...

April 14, 2023

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: April 7, 2023

April 7, 2023

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: March 31, 2023

// Biotech and Pharma Therapeutics AbbVie sidelines CytomX after seeing midphase oncology ADC data, opens talks on returning lead drug March 28, 2023 / AbbVie / CytomX Therapeutics / Antibody Drug Conjugates / Emerging Biopharma AbbVie has ditched its pact...

March 31, 2023

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: March 24, 2023

// Biotech and Pharma Therapeutics Novo Nordisk, Eli Lilly replenish Type 2 diabetes stars Ozempic, Mounjaro after off-label weight-loss boom March 20, 2023 / Novo Nordisk / Ozempic / Wegovy / Eli Lilly Ozempic, which has been in short supply...

March 24, 2023

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: March 3, 2023

// Biotech and Pharma Therapeutics After spending $6.5B for Momenta, J&J readies ‘pipeline in a product’ for pivotal year February 27, 2023 / Janssen Pharma / Myasthenia Gravis / Rheumatoid Arthritis / Neurology With over 10 indications already being explored...

March 3, 2023

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: February 10, 2023

// Biotech and Pharma Therapeutics AstraZeneca deals another blow to IL-12, dumping therapy to follow BMS, Merck KGaA out of race February 9, 2023 / AstraZeneca / Cytokines / Immuno-oncology / Solid Tumor Big Pharma involvement in IL-12 is fading...

February 10, 2023

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: February 3, 2023

// Biotech and Pharma Therapeutics Humira biosimilars arrive in the US, as Amgen launches first copycat to AbbVie’s blockbuster drug January 31, 2023 / Humira / Amgen / AbbieVie / New Drug Amgen’s drug, a so-called biosimilar named Amjevita, is...

February 3, 2023

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: January 27, 2023

// Biotech and Pharma Therapeutics J&J puts focus on cancer drugs in push to reach 2025 sales target January 24, 2023 / J&J / Cancer Drugs / Drugmaker Johnson & Johnson is confident it can reach its target of $60...

January 27, 2023

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: December 2, 2022

// Biotech and Pharma Therapeutics AstraZeneca beefs up COPD pipeline with $400M biobuck bet on C4X program November 28, 2022 / AstraZeneca / Chronic Obstructive Pulmonary Disease / Licensing Deals / Respiratory Diseases AstraZeneca has moved to strengthen its respiratory...

December 2, 2022

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: November 25, 2022

// Biotech and Pharma Therapeutics Boehringer Ingelheim embraces dual-pricing tactic with launch of unbranded Humira biosimilar October 4, 2023 / Boehringer Ingelheim / Humira / AbbVie / Biosimilars After debuting its branded Humira biosim Cyltezo in July, Boehringer has launched...

November 25, 2022

1 2 3 4 5 6

Tag: Alzheimer’s

Healthcare Industry News Weekly Wrap-Up: April 14, 2023

Healthcare Industry News Weekly Wrap-Up: April 7, 2023

Healthcare Industry News Weekly Wrap-Up: March 31, 2023

Healthcare Industry News Weekly Wrap-Up: March 24, 2023

Healthcare Industry News Weekly Wrap-Up: March 3, 2023

Healthcare Industry News Weekly Wrap-Up: February 10, 2023

Healthcare Industry News Weekly Wrap-Up: February 3, 2023

Healthcare Industry News Weekly Wrap-Up: January 27, 2023

Healthcare Industry News Weekly Wrap-Up: December 2, 2022

Healthcare Industry News Weekly Wrap-Up: November 25, 2022

Contact Us

Vault Bioventures HQ

Maximize Innovation

Strategic Clarity

Strategy⁺

About Vault

Tag: Alzheimer’s

Contact Us

Vault Bioventures HQ

Maximize Innovation

Strategic Clarity

Strategy+

About Vault

Strategy⁺